A WHO survey has found that access to HIV medicines has been severely impacted by COVID-19. Seventy-three countries have warned that they are at risk of stock-outs of antiretroviral (ARV) medicines as a result of the COVID-19 pandemic, according to the survey conducted ahead of the International AIDS Society’s biannual conference.